Wnt2, a canonical Wnt ligand, is implicated in esophageal squamous-cell carcinoma (ESCC) carcinogenesis, being absent in normal esophageal epithelium but present in over 50% of ESCC cases, with expression increasing with tumor grade [99]. Here, WNT2 is linked to neoplasm.